Search results for: pediatric rheumatology

Advocacy: It’s a Full-Contact Sport

James R. O'Dell, MD | June 10, 2012

Like so many things, it is about personal connections.

Bringing Fellows-in-Training to the Annual Meeting

Staff | June 10, 2012

The ACR supports fellows-in-training who wish to attend the ACR/ARHP Annual Meeting through the ACR Fellows Education Fund.

Medication Quick Guides Offer Infusion Staff a Streamlined Resource

Susan Richmond, MS, PA-C; Karla B. Jones, RN, MS, CPNP | June 10, 2012

The ACR/ARHP Medication Quick Guides offer easily accessable pharmaceutical information to rheumatologists.

Systemic Juvenile Idiopathic Arthritis

Rayfel Schneider, MBBCh, and Ronald M. Laxer, MDCM | May 9, 2012

Changing treatment paradigms in the biologic era

What’s In A Note?: The Use of Electronic Health Records

Simon M. Helfgott, MD | May 9, 2012

The dictum “to write as long as possible” has become the norm for some physicians. Quality, not quantity, should be our goal.

Growing Up Confident with Juvenile Idiopathic Arthritis

Staff | May 9, 2012

While juvenile arthritis can cause joint damage and limit function, rheumatologists strongly encourage children with JIA to live normal lives.

Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances

Gretchen Henkel | May 8, 2012

Dr. van der Heijde learned early in her career that serendipity often plays a role in clinical research and treatment advances.

Pinpoint Cognitive Dysfunction in Patients with Lupus

Vanessa Caceres | April 6, 2012

More than 80% of SLE patients experience some type of neurologic manifestation during their disease course. The challenge for rheumatologists and other clinicians lies in appropriately diagnosing any cognitive dysfunctions that accompany lupus and better understanding the causes and risk factors of those dysfunctions. “Cognitive Function in SLE” was the focus of a talk at the 2011 ACR/ARHP Annual Scientific Meeting in November.

The Mystery of IVIg

Eveline Wu, MD, Michael M. Frank, MD | March 8, 2012

Although initially given as replacement therapy for patients with primary and secondary immunodeficiency states, intravenous immunoglobulin (IVIg) has proven to be effective in the treatment of various autoimmune and inflammatory disorders. This success has led to a dramatic increase in the use of IVIg, with its use as an antiinflammatory agent now vastly surpassing its use in the treatment of immunodeficiencies. Even so, the basis for the antiinflammatory activity of IVIg remains unclear.

ACR Participates in Briefing to Highlight Importance of Biomedical Research

From the College | December 12, 2011

On September 13, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Coalition held a congressional briefing to commemorate the 25th anniversary of the organization’s honoring of congressional champions who have been instrumental in supporting NIAMS and the NIH. The Coalition is a group of more than 70 medical, patient-advocacy, and science-based organizations (including the ACR) dedicated to advancing the critical research of the NIAMS and the NIH. The Coalition’s mission is to elevate understanding of the value of the NIAMS among policy makers and the public to foster increased support of the Institute.